Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
Статья

Management of <i>Helicobacter pylori</i> infection—the Maastricht IV/ Florence Consensus Report

Peter MalfertheinerDepartment of Gastroenterology, Hepatology and Infectious Diseases, Otto-von-Guericke University of Magdeburg, Magdeburg, GermanyFrançis MégraudDepartment of Bacteriologie, INSERM U853, Université Bordeaux Segalen 2, Bordeaux, FranceColm O’MorainDepartment of Gastroenterology, Adelaide and Meath Hospital, Trinity College, Dublin, IrelandJ. AthertonSchool of Clinical Sciences, University of Nottingham, Nothingham, UKAnthony AxonFranco BazzoliInternal Medicine and Gastroenterology, University of Bologna, Bologna, ItalyGian Franco GensiniUniversity of Firenze, Firenze, ItalyJavier P. GisbertHospital Universitario de La Princesa, IP and CIBEREHD Madrid, SpainDavid Y. GrahamTheodore RokkasDepartment of Gastroenterology, Henry-Dunant Hospital, Athens, GreeceEmad El‐OmarDivision of Applied Medicine, Aberdeen University, Aberdeen, UKErnst J. KuipersErasmus MC University Medical Center, Rotterdam, The NetherlandsThe European Helicobacter Study Group (EHSG)
2012en
ABI

Аннотация

Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use, gastro-oesophageal reflux disease and extraintestinal manifestations of the infection. (2) Diagnostic tests and treatment of infection. (3) Prevention of gastric cancer and other complications. The results of the individual workshops were submitted to a final consensus voting to all participants. Recommendations are provided on the basis of the best current evidence and plausibility to guide doctors involved in the management of this infection associated with various clinical conditions.

Перевод пока недоступен

Идентификаторы

Цитирования и источники

Цитирований: 2Использованных источников: 0